Valley Forge-based AmerisourceBergen, one of the nation's biggest pharmaceutical wholesalers, said that chief financial officer Michael D. DiCandilo has left the company to "pursue other interests," effective immediately.
Tim G. Guttman, the company's vice president and corporate controller since 2002, will serve as acting CFO, the company said.
"Mike departs the company with an impeccable record of service over his 21 years, including the past ten as our chief financial officer," Steven H. Collis, president and chief executive officer of AmerisourceBergen said in a statement. "His tremendous contributions to the success of AmerisourceBergen through his fiscal leadership and business stewardship are greatly appreciated, and we wish him all the best in his future endeavors."
Guttman was previously Vice President, Finance of Syncor International, and held financial planning and financial services managerial positions at Disney Consumer Products, Pizza Hut, Inc. and PepsiCo, Inc.. Guttman started his career as a certified public accountant with accounting firm Deloitte & Touche.
DiCandilo could not be reached for comment.
- Pharmalot
- The Placebo Effect
- New York Times/Prescriptions
- Wall Street Journal/Health blog
- Financial Times
- Cafe Pharma
- Pharma Marketing
- Bio Century
- Bio Space
- Pharma Live
- Monday Morning
- In The Pipeline
- U.S. Department of Health and Human Services
- Food and Drug Administration
- Centers for Medicare and Medicaid
- Office of Inspector General, Health and Human Services
- OIG Most-wanted list of fugitives
- Centers for Disease Control and Prevention
- Securities and Exchange Commission/Edgar filings
- U.S. Attorney's Office/Eastern Pennsylvania, health-care fraud
- Clinical Trials
- Pharmaceutical Research and Manufacturers of America
- BIO
- Pennsylvania Association of Medical Suppliers
- Jersey Association of Medical Equipment Services
- Science Center
- American Health Lawyers Association
- Drug and Device Law
- Orange Book blog
- Taxpayers Against Fraud
- Adolor
- Almac
- AmerisourceBergen
- AstraZeneca
- Auxilium
- Bayer
- Celgene
- Cephalon
- Endo
- GlaxoSmithKline
- Johnson & Johnson
- Kensey Nash
- Lannett
- Merck
- Pfizer
- Roche
- Sanofi-aventis
- Shire
- Stryker
- Synthes
- Teva
- ViroPharma
- West














David Sell covers the pharmaceutical industry and related topics for The Inquirer’s Business Department. David has been a reporter and editor for more than 20 years. Contact him with tips and suggestions about news from the drug industry and the people who define an industry that touches nearly everyone and employs tens of thousands in the Philadelphia area.
Like David Sell and PhillyPharma 